Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Blood

• Publication date

  1991-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V77.9.1884.1884PMID 1850307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathophysiology and management of HIV-associated hematologic disorders.

  1989cited by this paper
• Human Fc gamma RIII (CD16). Isoforms with distinct allelic expression, extracellular domains, and membrane linkages on polymorphonuclear and natural killer cells.

  1989cited by this paper
• Anti‐D Immunoglobulin and Immune Thrombocytopenia – A Problem of Ethics in Blood Transfusion Practice

  1989cited by this paper
• Isolated thrombocytopenia in patients infected with HIV: Treatment with intravenous gammaglobulin

  1988cited by this paper
• Intravenous immunoglobulin (i.v. IgG) for previously treated acute or for chronic idiopathic thrombocytopenic purpura (ITP) in childhood: a prospective multicenter study

  1988cited by this paper
• Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin.

  1988cited by this paper
• Anti-RH immunoglobulin therapy for human immunodeficiency virus-related immune thrombocytopenic purpura.

  1988cited by this paper
• Transmission of viral infection by preparations of intravenous immunoglobulin

  1988cited by this paper
• Cost-effectiveness of splenectomy versus intravenous gamma globulin in treatment of chronic immune thrombocytopenic purpura in childhood.

  1988cited by this paper
• Anti‐D Immunoglobulin and Immune Thrombocytopenia —A Problem of Ethics in Blood Transfusion Practice

  1988cited by this paper
• Effect of danazol in immune thrombocytopenic purpura.

  1987cited by this paper
• Intravenous Treatment with Gammaglobulin in Adults with Immune Thrombocytopenic Purpura: Review of the Literature 1

  1987cited by this paper
• Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.

  1987cited by this paper
• Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D)

  1986cited by this paper
• Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody.

  1986cited by this paper
• Efficacy of rhesus antibodies (anti-Rh0 (D)) in autoimmune thrombocytopenia: Correlation with response to high dose IgG and the degree of haemolysis

  1986cited by this paper
• Treatment of refractory immune thrombocytopenic purpura with an anti-Fcγ-receptor antibody

  1986cited by this paper
• Effect of IgG anti‐Rho(D) in adult patients with chronic autoimmune thrombocytopenia

  1986cited by this paper
• Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin.

  1985cited by this paper
• Modulation of mononuclear phagocyte function by intravenous gamma-globulin.

  1984cited by this paper
• Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D))

  1984cited by this paper
• Defective B-lymphocyte function in homosexual men in relation to the acquired immunodeficiency syndrome.

  1984cited by this paper
• Intravenous immunoglobulin in immune thrombocytopenia.

  1983cited by this paper
• INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA

  1983cited by this paper
• The amount of platelet-bound albumin parallels the amount of IgG on washed platelets from patients with immune thrombocytopenia.

  1983cited by this paper
• Effect of intravenous immunoglobulin in immune thrombocytopenia.

  1983cited by this paper
• Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura.

  1983cited by this paper
• Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.

  1982influential reference
• Human neutrophil Fc gamma receptor distribution and structure.

  1982cited by this paper
• The nonspecific nature of platelet-associated IgG.

  1982cited by this paper
• High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

  1981cited by this paper
• Antigen-specific induction and regulation of antibody synthesis in cultures of human peripheral blood mononuclear cells.

  1980cited by this paper
• Pathophysiology of Immune Hemolytic Anemia

  1977cited by this paper
• Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura.

  1951influential reference

• Treatment of Immune Thrombocytopenia: Contextualization from a Historical Perspective

  2024cites this paper
• Ayurveda and Allopathic Therapeutic Strategies in Immune Thrombocytopenic Purpura: An Overview

  2023cites this paper
• The Cause and Effect of Immune Thrombocytopenia (ITP) on Individuals

  2023cites this paper
• Recent advances in treatments of adult immune thrombocytopenia

  2022cites this paper
• Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management

  2021cites this paper
• Transfusion Therapy in Specific Clinical Situations

  2021cites this paper
• Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP.

  2020cites this paper
• New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia

  2020cites this paper
• Engineering of Fc Multimers as a Protein Therapy for Autoimmune Disease

  2020cites this paper
• Passive Monoclonal and Polyclonal Antibody Therapies

  2019cites this paper
• Plasma-Derived Immunoglobulins

  2019cites this paper
• Concepts of Replacement Therapy: Blood Components, Blood Derivatives, and Medications

  2019cites this paper
• First-Line Therapy for Immune Thrombocytopenia

  2019cites this paper
• Can Some First-Line Therapies Induce Long-Term Remission ?

  2019cites this paper
• Treating murine inflammatory diseases with an anti-erythrocyte antibody

  2019cites this paper
• Anti-D: A Type of IVIg

  2018cites this paper
• Evaluation of treatment modalities of acute idiopathic throm- bocytopenic purpura in Al-zahraa teaching hospital in Al-Najaf

  2017cites this paper
• Others (Syk Inhibitor and Other Medications)

  2017cites this paper
• Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors

  2017cites this paper
• Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study.

  2017cites this paper
• Anti-RBC Antibody Mediated Erythrocyte Phagocytosis and its Therapeutic Role in Immune Thrombocytopenia (ITP)

  2016cites this paper
• High dose Intravenous Anti-D Immune Globulin is More Effective and Safe in Indian Paediatric Patients of Immune Thrombocytopenic Purpura.

  2016cites this paper
• Immunomodulation of immunothrombocytopenia.

  2016cites this paper
• Fc fusion as a platform technology: potential for modulating immunogenicity.

  2015cites this paper
• A monoclonal antibody with anti‐D–like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects

  2015cites this paper
• Comparison of dexamethasone and anti-D immune globulin for immune thrombocytopenia purpura in children

  2014cites this paper
• The Paradoxical Beneficial Effect on Thrombocytopenia in Refractory Immune Thrombocytopaenic Purpura by Leishmaniasis

  2014cites this paper
• Case 27-2013

  2013cites this paper
• Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?

  2013cites this paper
• Case records of the Massachusetts General Hospital. Case 27-2013. A 6.5-month-old boy with fever, rash, and cytopenias.

  2013cites this paper
• Rozrolimupab, a first-in-class recombinant monoclonal antibody product for primary immune thrombocytopaenia

  2013influential citation
• Acute renal failure in a child with thrombocytopenic purpura caused by acute Epstein-Barr virus infection after treatment with anti-D immunoglobulin.

  2013cites this paper
• Immune Thrombocytopenia (ITP)

  2013cites this paper
• Rozrolimupab, a mixture of recombinant human monoclonal anti‐D antibodies, for the treatment of primary immune thrombocytopenia – a review

  2013cites this paper
• Molecular and Cellular Pathways Involved in the Anti-inflammatory Activity of IgG

  2013cites this paper
• model of ITP: an alternative to IVIG Monoclonal IgG can ameliorate immune thrombocytopenia in a murine

  2013cites this paper
• Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura

  2013cites this paper
• Intravenous immunoglobulin-induced hemolytic anemia in a patient with juvenile dermatomyositis.

  2013cites this paper
• HIGHLIGHTS OF PRESCRIBING INFORMATION

  2013cites this paper
• antibodies, in the treatment of primary immune thrombocytopenia Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD

  2012cites this paper
• Childhood immune thrombocytopenia: Clinical presentation and management

  2012cites this paper
• Mechanisms of Disease Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases

  2012cites this paper
• Childhood immune thrombocytopenia: Clinical presentation and management.

  2012cites this paper
• Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia.

  2012cites this paper
• Immune Complex Therapies for Treatment of Immune Thrombocytopenia

  2012cites this paper
• Immune thrombocytopenic purpura: Historical perspective, current status, recent advances and future directions

  2012cites this paper
• Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice

  2012cites this paper
• Therapeutic options for immune-mediated thrombocytopenia.

  2012cites this paper
• RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)

  2012cites this paper
• Intravenous immune globulin in autoimmune and inflammatory diseases.

  2012cites this paper
• A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression

  2012cites this paper
• Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics.

  2011cites this paper
• Transfusion Therapy in Specific Clinical Situations

  2011cites this paper
• Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters

  2011cites this paper
• Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP).

  2011cites this paper
• Efficacy and safety of rituximab in common variable immunodeficiency‐associated immune cytopenias: a retrospective multicentre study on 33 patients

  2011cites this paper
• Hematology and Oncology Problems in the Intensive Care Unit

  2011cites this paper
• C2 Plasma-derived immunoglobulins

  2011cites this paper
• ITP: a historical perspective

  2011cites this paper
• Antibody‐mediated modulation of immune responses

  2010cites this paper
• Mechanisms of action of intravenous immunoglobulins

  2010cites this paper
• Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study.

  2010cites this paper
• Splenectomy for Children and Adults with Persistent and Chronic Immune Thrombocytopenia: Long term results.

  2010cites this paper
• Subcutaneous anti-d globulin application is a safe treatment option of immune thrombocytopenia in children

  2010cites this paper
• IMPROVED MOUSE MODELS FOR THE STUDY OF TREATMENT MODALITIES USING SULFUR- CONTAINING SMALL-MOLECULAR-WEIGHT MOLECULES FOR PASSIVE IMMUNE-MEDIATED THROMBOCYTOPENIA

  2010cites this paper
• The Effectiveness and Safety of the Thrombopoetin Agonist Romiplostim in the Treatment of Adults with Chronic Idiopathic Thrombocytopenic Purpura

  2010cites this paper
• Patients' Benefit-Risk Preferences for Chronic Idiopathic Thrombocytopenic Purpura Therapies

  2010cites this paper
• Investigation of whether the acute hemolysis associated with Rho(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model

  2009cites this paper
• Efficacy and safety of anti-D for treatment of adults with immune thrombocytopenia

  2009cites this paper
• Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia.

  2009cites this paper
• 13 Management of Immune Thrombocytopenic Purpura in Adults

  2009cites this paper
• Romiplostim in chronic immune thrombocytopenic purpura.

  2009cites this paper
• Therapeutic approaches to secondary immune thrombocytopenic purpura.

  2009cites this paper
• Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia

  2009cites this paper
• Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia

  2009cites this paper
• Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science.

  2009cites this paper
• New Drug Romiplostim in Chronic Immune Thrombocytopenic Purpura

  2009cites this paper
• What is the mechanism for acute hemolysis occurring in some patients after intravenous anti‐D therapy for immune thrombocytopenic purpura?

  2009cites this paper
• Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

  2009cites this paper
• Management of Chronic Childhood Immune Thrombocytopenic Purpura: AIEOP Consensus Guidelines

  2009cites this paper
• One year follow‐up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab

  2009cites this paper
• Intravenous Anti-D immunoglobulin treatment of adult chronic immune thrombocytopenic purpura (ITP)

  2008cites this paper
• Recurrent transfusion‐related acute lung injury after fresh frozen plasma in a patient with hereditary factor V deficiency

  2008cites this paper
• Complete remission in a case of severe multi‐resistant idiopathic thrombocytopenic purpura after Helicobacter pylori eradication

  2008cites this paper
• Delayed hemolysis after intravenous anti‐D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura

  2008cites this paper
• The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?

  2008cites this paper
• Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura

  2008cites this paper
• History of immunoglobulin replacement.

  2008cites this paper
• Rapid diffuse alveolar hemorrhage associated with all‐trans‐retinoic acid and filgrastim

  2008cites this paper
• Prevention of D sensitization after mismatched transfusion of blood components: toward optimal use of RhIG

  2008cites this paper
• Comparative pharmacokinetics of liquid and lyophilized formulations of IV RhIG immune globulin.

  2008cites this paper
• Weekly long-term intravenous immunoglobulin for refractory parvovirus B19 and Epstein-Barr virus-induced immune thrombocytopenic purpura.

  2008cites this paper
• Unexpected CNS localization in M2 acute myeloid leukemia: A link with past heroin addiction?

  2008cites this paper
• Anti-inflammatory actions of intravenous immunoglobulin.

  2008cites this paper
• Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac®) in chronic immune thrombocytopenic purpura

  2007cites this paper
• Immune thrombocytopenic purpura.

  2007cites this paper
• Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis

  2007cites this paper
• Management of immune thrombocytopenic purpura

  2007cites this paper
• Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.

  2007cites this paper
• Severe thrombocytopenia and human immunodeficiency virus infection. Report of two cases and review

  2007cites this paper